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Abstract
Total daily intakes of diethyl phthalate (DEP), di(n-butyl) phthalate (DnBP), di(isobutyl) phthalate (DiBP), butyl benzyl
phthalate (BBzP) and di(2-ethylhexyl) phthalate (DEHP) were calculated from phthalate metabolite levels measured in the
urine of 431 Danish children between 3 and 6 years of age. For each child the intake attributable to exposures in the indoor
environment via dust ingestion, inhalation and dermal absorption were estimated from the phthalate levels in the dust
collected from the child’s home and daycare center. Based on the urine samples, DEHP had the highest total daily intake
(median: 4.42 mg/d/kg-bw) and BBzP the lowest (median: 0.49 mg/d/kg-bw). For DEP, DnBP and DiBP, exposures to air and
dust in the indoor environment accounted for approximately 100%, 15% and 50% of the total intake, respectively, with
dermal absorption from the gas-phase being the major exposure pathway. More than 90% of the total intake of BBzP and
DEHP came from sources other than indoor air and dust. Daily intake of DnBP and DiBP from all exposure pathways, based
on levels of metabolites in urine samples, exceeded the Tolerable Daily Intake (TDI) for 22 and 23 children, respectively.
Indoor exposures resulted in an average daily DiBP intake that exceeded the TDI for 14 children. Using the concept of
relative cumulative Tolerable Daily Intake (TDIcum), which is applicable for phthalates that have established TDIs based on
the same health endpoint, we examined the cumulative total exposure to DnBP, DiBP and DEHP from all pathways; it
exceeded the tolerable levels for 30% of the children. From the three indoor pathways alone, several children had
a cumulative intake that exceeded TDIcum. Exposures to phthalates present in the air and dust indoors meaningfully
contribute to a child’s total intake of certain phthalates. Such exposures, by themselves, may lead to intakes exceeding
current limit values.
Citation: Beko¨ G, Weschler CJ, Langer S, Callesen M, Toftum J, et al. (2013) Children’s Phthalate Intakes and Resultant Cumulative Exposures Estimated from Urine
Compared with Estimates from Dust Ingestion, Inhalation and Dermal Absorption in Their Homes and Daycare Centers. PLoS ONE 8(4): e62442. doi:10.1371/
journal.pone.0062442
Editor: Jaymie Meliker, Stony Brook University, Graduate Program in Public Health, United States of America
Received January 24, 2013; Accepted March 21, 2013; Published April 23, 2013
Copyright:  2013 Beko¨ et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Danish VILLUM FOUNDATION generously supported the study (Grant # VKR020814). The funder had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gab@byg.dtu.dk
Introduction
Phthalates are a group of ubiquitous chemicals present in many
consumer products, including building materials, furnishings,
clothing, paints, food packaging, toys, personal care products
and pharmaceuticals. Many of them are or have been produced in
very large quantities. Phthalates can be released into the
environment by leaching, evaporation, migration, abrasion or
application of phthalate-containing personal care products. Due to
their widespread use, the general population is continuously
exposed to phthalates.
A large number of human and animal studies have focused on
possible health effects of phthalate exposure. Articles reviewing the
available literature are frequently published, and we refer to them
for further details on the health effects of phthalate exposure.
Briefly, phthalates are known to be developmental and re-
productive toxicants. Indications exist that they may impact
genital development, semen quality, children’s neurodevelopment,
thyroid function, onset of puberty in females and that they may
possibly cause respiratory problems
[1],[2],[3],[4],[5],[6],[7],[8],[9]. Recent studies indicate that pre-
natal phthalate exposure may influence a child’s mental,
psychomotor and behavioral development [10],[11],[12],[13],
sex hormone status in newborns [14] and the risk of developing
eczema in early childhood [15]. DEHP exposure of fertile men can
be associated with minor alterations of markers of free testosterone
[16]. DEHP metabolites were found at increased levels in children
with autism [17] and school children with lower vocabulary and
IQ scores [18]. Additionally, Toft et al. [19] found an association
between periconceptional urinary concentration of MEHP, the
primary metabolite of DEHP, and pregnancy loss. Exposure to
certain phthalates may be associated with delayed pubarche in
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e62442
girls [20], obesity [21], biomarkers for inflammation and oxidative
stress [22] and the genesis of diabetes [23]. Furthermore, there is
some evidence that the secondary oxidized metabolites of DEHP
may themselves be developmental toxicants [24],[25].
In the European Union the use of several phthalates in toys,
child care articles and personal care products has been restricted
based on either their classification as reproductive/developmental
toxicants or the precautionary principle [26]. In February 2011
the European Parliament decided to phase out the use of DnBP,
BBzP and DEHP by August 2015 (Annex XIV to Regulation
No. 1907/2006 for Registration, Evaluation, Authorization and
Restriction of Chemicals - REACH). Moreover, various author-
ities have established limit values for the intake of certain
phthalates [27]. Limit values that are most often used are the
Reference Dose (RfD) established by the US EPA and the
Tolerable Daily Intake (TDI) established by the European Food
Safety Authority (EFSA). Separate values have been established for
different phthalates (see Table 1). Recent animal studies suggest
that phthalates and other potential endocrine disrupting chemicals
can act in a dose-additive manner
[28],[29],[30],[31],[32],[33],[34],[35], [36]. The development of
a method to evaluate the cumulative exposure to anti-androgenic
chemicals has been advocated for some time [37],[38]. One such
approach for assessing cumulative risk of phthalate exposure, the
relative cumulative Tolerable Daily Intake (TDIcum), has been
introduced by Koch et al. [26] in analogy to the Hazard Index
(HI) [39],[38] and was recently reported by Søeborg et al. [40] for
129 Danish children and adolescents.
The potential pathways of exposure are ingestion, inhalation
and dermal absorption. Dietary ingestion has long been believed
to constitute the major source of exposure to high molecular
weight phthalates. Ingestion of dust and, to some extent, personal
care products, as well as mouthing of toys and other articles, may
further contribute to ingestion exposures. Inhalation of air,
airborne particles and aerosols from various sprays may also
make a meaningful contribution. Dermal exposure through the
use of personal care products and dermal contact with plastic
products, soil and dust can add to the total intake of certain
phthalates [41],[42],[43],[44],[45],[46],[47],[48],[49]. Additional-
ly, recent studies argue that air-to-skin transdermal uptake may be
a meaningful pathway for lower molecular weight phthalates
[50],[51],[52],[53],[54]. This phthalate exposure pathway has
only been included in one earlier study [54]. The relative
contribution of each pathway to an individual’s total exposure
varies with the phthalate and the age of the exposed individual
[41],[43]. Infants and children tend to be more exposed than
adults. This may partially be a consequence of added skin contact
with surfaces and frequent mouthing of fingers and other objects
such as plastic toys. The higher rate of dust ingestion and ingestion
of phthalates present in breast milk, infant formula, cow’s milk or
food packaging may further lead to higher phthalate exposures for
children [7],[55]. In indoor settings, phthalates partition between
the gas-phase and airborne particles, settled dust and exposed
surfaces, including exposed skin and hair [56],[51]. The contri-
bution to total exposure from exposures that occur in the indoor
environment can be substantial for certain phthalates and age
groups [41],[43].
Current limit values are mainly based on oral intake of
phthalates. Limit values for intake via other pathways do not
exist. However, absorption, distribution, and elimination of
a chemical in the body differ for different exposure pathways
[57],[58],[59]. Ingested compounds pass through the intestines
and liver before entering the blood. Inhaled contaminants first
pass through the lungs. Chemicals penetrating the skin can directly
enter the blood. For nominally comparable exposures, the
resulting biologically effective dose to various organs can be
different for different exposure routes [60]. Therefore, under-
standing the contribution of each pathway to the total intake may
well be important from a health-effects perspective.
Improved understanding of the metabolism and elimination of
phthalates makes it possible to estimate total daily phthalate
intakes, from all pathways and sources, based on the concentra-
tions of phthalate metabolites in the urine
[61],[62],[63],[64],[65],[66]. During the last decade there has
been a substantial increase in studies that have used this approach
to investigate phthalate exposures [67],[68]. Studies using human
biomonitoring often only attempt to determine the total intake or
intake from a specific source such as diet or personal care products
[69],[70],[45]. Several studies have attempted to estimate
phthalate intakes from different sources and pathways using
various models
[71],[72],[73],[74],[75],[76],[41],[42],[77],[52],[53]. The study
closest in design to the present study is that by Guo and Kannan
[43], which estimated phthalate intakes from dust ingestion,
inhalation and dermal uptake (only considering dust adhered to
skin) after measuring phthalate levels in dust collected from homes.
Table 1. Properties of the target phthalates and their metabolites used for the estimation of phthalate intake from the
concentration in urine and from phthalate exposures in the indoor environment.
Parent phthalate MW1 (g/mol) log(Koa) (2) kp_g (m/h) f1 (2) TDI (mg/d/kg-bw) Metabolite MW2 (g/mol) Fue (2)
DEP 222 8.21 3.4 0.0414 500 MEP 194 0.69a
DnBP 278 9.83 4.8 0.0314 10 MnBP 222 0.69
DiBP 278 9.62 4.8 0.0243 10c MiBP 222 0.69a
BBzP 312 11.6 5.9 0.0143 500b MBzP 256 0.73
DEHP 391 12.9 5.8 0.0021 50b MEHP 294 0.059
MEHHP 294 0.233
MEOHP 292 0.15
MECPP 308 0.185
See text for description of variables.
aNo excretion factor available at the time of data analysis; factor for MnBP was used [67].
bFor comparison: Reference dose value RfD for BBzP is 200 mg/d/kg-bw, for DEHP 20 mg/d/kg-bw [97],[98].
cputative TDI by analogy to DnBP.
doi:10.1371/journal.pone.0062442.t001
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The results were then compared to total intakes estimated from
metabolites measured in urine. However, the study populations for
urine sampling and dust sampling were not identical. Nor did the
authors have information on physical characteristics, such as body
weight. Thus, the analyses were performed using median values of
the measured parameters coupled with recommended exposure
factors. All indoor exposures were assumed to occur in the same
environment. We are unaware of any study that has measured
phthalate levels in dust and metabolite levels in urine for the same
study population, and compared phthalate intakes from co-
occurring exposure pathways to total intakes on a person-by-
person basis.
The Danish Indoor Environment and Children’s Health (IECH) study
is an investigation of potential associations between different
indoor environmental factors and children’s health, especially
allergies and asthma [78]. As part of this study, detailed
investigations of the living environments of 200 children with
parental-reported asthma and/or allergy (cases) and 300 randomly
selected bases between 3 and 6 years of age were performed. These
included collection of settled dust samples from both their
bedrooms and daycare centers (DCC). The children also received
a detailed examination by a medical doctor, at which time urine
samples were collected from 441 of the children. Langer et al. [79]
reports the mass fractions of five phthalate esters in the dust
samples – DEP, DnBP, DiBP, BBzP and DEHP – and compares
the results from the dust samples with those from other studies.
Langer et al. [80] reports the concentration of eight metabolites of
these phthalates in the urine – monoethyl phthalate (MEP) from
DEP, mono-n-butyl phthalate (MnBP) from DnBP and BBzP,
mono-isobutyl phthalate (MiBP) from DiBP, monobenzyl phtha-
late (MBzP) from BBzP, mono(2-ethylhexyl) phthalate (MEHP)
from DEHP; and three secondary metabolites: mono-2-ethyl-5-
hydroxyhexyl phthalate (MEHHP), mono-2-ethyl-5-oxohexyl
phthalate (MEOHP) and mono-2-ethyl-5-carboxypentyl phthalate
(MECPP), each from DEHP – and compares the results from the
urine samples with those of other studies. The Langer et al. [80]
paper also presents correlations between phthalate levels in dust
collected from the children’s home and daycare center and the
concentrations of metabolites in corresponding urine samples. The
present paper builds on these data, critically examining the
pathways by which children are exposed to phthalates in the
indoor environment. We calculate total daily intakes (DI) of the
target phthalates based on metabolite levels in the urine samples.
For each child and each phthalate, we then compare these with
estimated intakes from dust ingestion, inhalation and dermal
absorption that occurred in the child’s home and daycare center.
We conclude by comparing these intakes, estimated from either
the urine samples or the indoor dust samples, with established
Tolerable Daily Intake (TDI) values.
Materials and Methods
Ethics Statement
The study was approved by The Regional Scientific Ethical
Committee for Southern Denmark (Case # S-20070108). Both
verbal and written informed consent was obtained from the
parents/guardians on behalf of all children participating in the
study.
Data Collection and Estimated Intakes
Between March and May 2008, dust samples were collected
from the homes of 500 children and from the 151 daycare centers
that these children attended in Odense, Denmark. Morning urine
samples from 441 children were collected between August 2008
and April 2009. Detailed descriptions of the study population, dust
sampling, urine sampling and their chemical analyses are
presented elsewhere [78],[79],[80]. These studies also report the
mass fractions of phthalates in the dust and the levels of phthalate
metabolites in the urine (see Table S1 for a summary of these
results).
In the present paper, the daily intake of the target phthalates,
normalized for body weight, has been calculated for each child
from the phthalate metabolite concentration in the urine (DIurine).
Using the mass fractions of phthalates in the dust collected from
the children’s homes and daycare centers, the co-occurring
airborne concentrations (both gas phase and associated with
airborne particles) of these phthalates were estimated. Next the
children’s intakes of the target phthalates via inhalation, dust
ingestion and dermal absorption were estimated for both the home
and daycare environments. The total daily intake from the indoor
environment was then calculated for the day of week the urine
sampling occurred (DIindoors). Additionally, the total weekly intake
(WI) from the indoor environment was calculated (WIindoors), and
one-seventh of this value was termed the average daily intake from
a week-long exposure. These analyses were conducted for 431
children from whom urine samples were collected and for whom
dust samples from both home and daycare center were available.
Daily Intakes from Urinary Phthalate Metabolite
Concentrations (DIurine)
The daily intake of phthalates was estimated for each child from
the concentrations of metabolites in its morning urine sample
using equation (1) - the urinary volume-based calculation
approach. We did not adjust our values using the creatinine
correction approach for reasons outlined in Langer et al. [80].
DIurine~(Cu|Vu|
1
Fue
|
MW1
MW2
)=W mg=d=kg-bwð Þ ð1Þ
where DIurine is the total daily intake normalized for body weight
(unit: mg per day per kg of body weight; mg/d/kg-bw), Cu is the
urinary phthalate metabolite concentration (mg/L), Vu is the daily
excreted urinary volume (L/d) calculated from the estimated daily
urine excretion rate of 22.4 mL/kg body weight [81],[82] and the
child’s body weight (W; kg), Fue is the urinary excretion factor
which describes the molar ratio between the excreted amount of
a metabolite in relation to the intake of the parent phthalate
(values taken from Table 1 of Wittassek et al. [68]), MW1 and
MW2 are the molar weights of the parent phthalate and its
metabolite, respectively (g/mol). The body weight of the children
was measured on the day of urine sampling.
The final total daily intake of DEHP was calculated as the
average intake obtained from equation (1) for the secondary
metabolites of DEHP (MEHHP, MEOHP and MECPP). MEHP
was not used to estimate the daily intake of DEHP since it is prone
to contamination, has a much shorter elimination half-life and
tends to be present at lower concentrations than the secondary
metabolites [83],[84],[85],[86],[68],[87],[88],[89].
Day-specific Intakes from Indoor Environment (DIindoors)
The intakes from dust ingestion, inhalation and dermal
exposure were first determined separately for the home and
daycare environments, using the equations in Table 2. In making
these calculations, we assumed that a child spent 20 hours a day in
their home and daycare environments. Four hours were assumed
to be spent in transit, outdoors and in other indoor environments.
We further assumed that: a child spent 9 hours asleep; on
Children’s Phthalate Intake and Exposure Pathways
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a weekday a child spent 8 hours in daycare, 6 of which were
indoors; on a weekday a child spends 14 hours at home, of which
the child was awake 5 hours; on a weekend all 20 hours indoors
were spent at home, of which the child was awake 11 hours.
The mass fractions of phthalates in the dust collected from the
home or daycare center (Cdust) have been published elsewhere [79].
The daily dust ingestion rate (Mingest_dust) was assumed to be
60 mg/day [90]. Assuming that a child does not ingest dust while
sleeping, the 60 mg of dust ingested in a day occurs during the 15
waking hours (4 mg/hour). This prorates to 44 mg/day ingested
during the 11 hours spent awake in the home and daycare
environments. We assumed that during weekdays a child ingests
20 mg/day (4 mg/hour6 5 hours) of dust at home and 24 mg/
day (4 mg/hour66 hours) in daycare, while during the weekend
44 mg/day is ingested in the home.
The total daily inhalation rate (Vinhalation) of a child between 3
and 6 years of age was assumed to be 10.9 m3/d [90]. Based on
short-term inhalation rates stratified by activity level in the EPA’s
child-specific exposure factors handbook, we estimated that the
volume of air inhaled during the 6 hours spent indoors in daycare
was 2.8 m3 (3 hours sedentary and 3 hours light activity), while the
volume inhaled during the 14 hours spent indoors at home on
a weekday was 5.2 m3. During a Saturday or Sunday, the volume
inhaled during the 20 hours spent indoors at home was estimated
to be 8 m3.
DEP is the most volatile of the five targeted phthalates. In the
air it exists almost entirely in the gas phase and its presence in
airborne particles makes a negligible contribution to its overall
airborne concentration. In the present study, the gas phase
concentration of DEP, Cg (DEP), was estimated by assuming
a linear relationship between its mass fraction in settled dust,
Cdust(DEP), and its gas phase concentration [56]. We used data
from three previous studies that had made simultaneous measure-
ments of DEP’s mass fraction in settled dust and its airborne
concentration [75],[91],[92] to establish the parameters that
defined the approximately linear relationship:
Cg(DEP)~
Cdust(DEP)z0:2381
0:0092
ng=m3
  ð7Þ
where the units for Cdust(DEP) are mg/g. The coefficient of
determination for the relationship was R2= 0.99.
The four other targeted phthalates, DnBP, DiBP, BBzP and
DEHP, have meaningful concentrations in both the gas phase and
in airborne particles, Cp. In the case of these phthalates, we began
by assuming that the logarithm of (Cdust/Cg) for a given phthalate
was a linear function of the logarithm of its octanol-air partition
coefficient, log(Koa) [56]. We used data from four previous studies
[75],[91],[92],[93] to establish the parameters that defined this
approximately linear relationship:
log (
Cdust
Cg
)~1:0598| log (Koa){11:422 {ð Þ ð8Þ
The coefficient of determination for the resulting relationship
was R2= 0.94. Using this approach, we could calculate Cdust/Cg for
each phthalate, and then estimate its gas phase concentration in
Table 2. Equations used in the calculation of daily intakes (mg/d/kg-bw) of phthalates by dust ingestion, inhalation and dermal
exposure.
Pathway No. Equation Parameters
Dust ingestion (2)
DIingest dust~(Cdust|Mingest dust)=W
Cdust is the mass fraction of phthalates in dust (mg/g),
Mingest_dust is the daily dust ingestion rate (g/day)
Inhalation (3)
DIinhalation~(
(CgzCp )|Vinhalation
1000
)=W
(Cg+Cp) is the total airborne concentration of a phthalate -
both the gas phase concentration (Cg) and the mass sorbed
to particles (Cp) per unit volume of air (ng/m
3), Vinhalation is
the daily volume of air inhaled (m3/d)
Dermal exposure
through air
(4)
DIdermal gas~(
Cg|kp g|A|t
1000
)=W
kp_g is the indoor air transdermal permeability coefficient
(m/h), A is the child’s body surface area (m2), t is the daily
duration of exposure (h)
Dermal exposure
through dust
adhered to skin
(5)
DIdermal dust~(Cdust|
A
4
|Ms|f1|0:15|
t
24
)=W
A/4 is the skin surface area contaminated with dust particles,
Ms is the amount of dust adhered to skin (g/m
2), f1 is the
fraction of phthalates transferred through the skin into the
body, 0.15 is the fraction of phthalates in dust adhered to
skin available for absorption (matrix effect)
Other (6)
DIother~DIurine{DIingest dust{DIinhalation{DIdermal gas
See text for further details on the parameters used in the equations.
doi:10.1371/journal.pone.0062442.t002
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either a home or daycare center from its mass fraction measured in
the dust sample taken from the home or daycare center.
For these four phthalates, we also needed to estimate their total
airborne concentrations (Cg+Cp). To do this we assumed that the
gas phase concentration of a given phthalate was related to its
particle phase concentration through a partition coefficient, Kp,
and that the relationship between its gas phase concentration and
its total airborne concentration was given by equation (9) [56]:
Cg~
CgzCp
1z(TSP|Kp)
ng=m3
  ð9Þ
where TSP is the average indoor mass concentration of airborne
particles, assumed to be 20 mg/m3. Kp for a given phthalate was
estimated using equation (10) [56]:
Kp~
fom part|Koa
rpart
m3

mg
  ð10Þ
where fom_part is the volume fraction of organic matter associated
with airborne particles, assumed to be 0.4 (-) [94]; Koa is the
phthalate’s octanol-air partition coefficient (-) [56]; and rpart is
the density of airborne particles, assumed to be 16 10212 mg/
m3.
The daily intake of phthalates via dermal absorption was
estimated for two pathways: i) transport of gas-phase phthalates
through the air to the skin and then through the epidermis into
dermal capillaries (DIdermal_gas, eq. (4) in Table 2) and ii) transport
from dust adhered to the skin into dermal capillaries (DIdermal_dust,
eq. (5) in Table 2). The former was estimated using an approach
outlined in Weschler and Nazaroff [51], using the indoor air
transdermal permeability coefficient (kp_g), which describes the
transport of a gas-phase phthalate from air in the core of a room
through the boundary layer adjacent to skin and then through the
stratum corneum/epidermis to dermal capillaries. The child’s
body surface area was calculated from the child’s weight and
height using the relationship reported by Dubois and Dubois [95]:
A~
W 0:725|H0:425|71:84
10000
m2
  ð11Þ
where H is the child’s height (cm).
When calculating DIdermal_dust, we assumed only 25% of the total
skin surface area to be contaminated with dust particles. The
amount of dust adhered to the skin (Ms) was assumed to be 0.96 g/
m2 [43]. To account for reduced absorption caused by physical-
chemical bonding to dust (the matrix effect), we used a coefficient
of 0.15, which represents the fraction of phthalates available for
dermal absorption [96]. The fraction of the available phthalate
actually transferred through the skin into the body (f1) [41] is
shown for each phthalate in Table 1, which lists selected physical-
chemical properties of the five target phthalates as well as their
tolerable daily intakes (TDI). Also listed are selected properties of
their metabolites. Preliminary analysis indicated that the contri-
bution to total intake resulting from phthalates associated with
dust adhered to skin was negligible; hence DIdermal_dust was not
included in further analyses (see Results and Discussion).
Phthalate metabolism occurs on a scale of hours
[99],[100],[89],[101]. All urine samples were collected in the
morning after the child awoke. In the case of a urine sample
collected on a Monday (n= 120) or Sunday (n= 1), metabolites
resulting from daycare exposures occurring on Friday had
presumably been excreted prior to urine collection, and the final
day-specific phthalate intake (DIpathway_final) was based solely on
exposures occurring in the home during the weekend. For children
whose urine samples were taken on other days, the final intake
resulting from indoor exposures was calculated by combining the
intakes that occurred in the daycare and home environments. For
the purpose of comparing intakes estimated for indoor pathways
with total daily intakes estimated from urine samples (DIurine), we
roughly corrected for metabolism and excretion that occurred
during the 24 hours prior to urine sampling. As the exposure in the
daycare center occurred ,15 hours before urine sampling (about
two or more half-lives for most of the metabolites) we reduced the
contribution from the 6-hour indoor exposure in the daycare by
a factor of four:
DIpathway final weekday~DIhom e 14z
DIdcc
4
mg=d=kg-bwð Þ ð12Þ
where DIhome_14 is the daily intake from 14 hours of day- and
nighttime exposure in the home (occurring both on weekdays and
weekends) and DIdcc is the daily intake from 6 hours of exposure in
the daycare center during the day before urine sampling. In order
to produce comparable results for the weekends, we similarly
reduced an identical portion of the intake from the home during
the weekend:
DIpathway final weekend
~DIhom e 14z
DIhom e 6
4
mg=d=kg-bwð Þ
ð13Þ
where DIhome_6 is the daily intake from 6 hours of daytime
exposure in the home.
For a given child, daily phthalate intake resulting from indoor
exposures on the day prior to urine sampling was calculated as the
sum of intakes by three exposure pathways:
DIindoors~DIingest dustzDIinhalation
zDIdermal gas mg=d=kg-bwð Þ
ð14Þ
The net intake from other pathways such as diet, the outdoor
environment or indoor environments other than the home and
daycare (DIother) was calculated from equation (6) in Table 2.
Average Daily Intake from a Week-long Exposure
(WIindoors/7)
To estimate the average daily phthalate intake from the indoor
environment, regardless of the time of urine sampling, we first
calculated the weekly intake using the following weighting scheme
for each pathway:
WIpathway final~(5|DIhom e 14)z(5|DIdcc)
z(2|DIhom e 20) mg=week=kg-bwð Þ
ð15Þ
where DIhome_14 is the daily intake from 14 hours of day- and
nighttime exposure in the home during weekdays, DIdcc is the daily
intake from 6 hours in the daycare during weekdays and DIhome_20
is the daily intake from 20 hours spent in the home during
Saturday or Sunday (weekend). The weekly intakes for each
pathway were then summed into WIindoors similar to equation (14).
One-seventh of this value is the average daily intake from a week-
long exposure. Additionally, we determined the fraction of the
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total weekly intake (WIindoors) attributable to each pathway. We also
calculated the fraction of WIindoors and the fraction of the weekly
intake from each pathway (WIpathway_final) attributable to the home
and daycare environments separately.
The results of DIurine and WIindoors/7 were compared to the
tolerable daily intake (TDI) values derived by the European Food
Safety Authority for BBzP, DnBP and DEHP [102],[103],[104].
In the case of DiBP, since there is no established limit value, the
TDI for DnBP was used. The TDI value for DEP was taken from
a statement on dietary exposure to phthalates by the Committee
on Toxicity of Chemicals in Food, Consumer Products and
Environment [105]. Based on different health effects, the US EPA
recommends a daily oral Reference Dose (RfD) lower than the
TDI for BBzP and DEHP [97],[98]. We also compare our intake
levels of these phthalates to the EPA’s RfDs.
To evaluate the cumulative exposure to several endocrine active
(anti-androgenic) phthalates that may act in a dose-additive
manner, we applied the concept of a relative cumulative Tolerable
Daily Intake (TDIcum) introduced by Koch et al. [26]. A TDIcum
above 100% indicates that the cumulative daily phthalate intake
surpasses the tolerable levels. As suggested by Koch et al. [26], we
restricted our analyses to phthalates whose TDIs were based on
the same health endpoint (DnBP, DiBP and DEHP):
TDIcum~(
DIDnBP
TDIDnBP
z
DIDEHP
TDIDEHP
z
DIDiBP
TDIDiBP
)|100 %ð Þ ð16Þ
The TDIcum was determined both for phthalate intakes obtained
from the urinary phthalate concentrations (DIurine) and for the
average daily intakes from a week-long exposure (WIindoors/7).
Spearman correlation coefficients were calculated between DIurine
and DIindoors. Statistical analyses were done in STATA software,
release 11.0 for Windows (StataCorp LP, College Station, Texas,
USA).
Results
Figures 1A through 1E present distribution plots of the total
intakes (DIurine) and intakes on the day before urine sampling from
the three pathways for the individual phthalates (logarithmic scale
for the y-axis) against the cumulative distribution function with the
x-axis scaled according to the normal error function. For a given
phthalate, the distribution curves for all three pathways have
roughly the same slope. Comparable distribution slopes were
observed for intakes calculated from urine and those calculated
from dust mass fractions. The only exceptions were the slopes of
the daily intakes for DEP from the three indoor exposure
pathways, which were larger than the slope of the intake calculated
from urine. The slope of the distribution of dust mass fractions of
DEP was also larger than that of other phthalates, presumably
reflecting a wide variation in the use of personal care products
[79]. For some of the phthalates, the day-specific intakes via
ingestion, inhalation and dermal absorption had skewed tails,
reflecting a number of dust mass-fraction values below the
detection limit. In contrast, distributions without skewed tails
were obtained for the average daily intakes estimated from a week-
long exposure (WIindoors/7), which were determined based on
exposure in both environments for all children, regardless of the
day of urine sampling (Figure S1). Apart from the tails, most of the
plots are approximately linear, indicating that the distributions are
better described as ‘‘log-normal’’ rather than ‘‘normal’’. There-
fore, in what follows we refer to the median values when
describing the results.
Table 3 compares total daily intakes estimated from metabolite
concentrations in the urine samples (DIurine) with those estimated
from dust ingestion, inhalation and dermal absorption occurring
on the day before urine sampling. Descriptive statistics for the sum
of the three indoor pathways are also presented in this table. Total
daily intake, as estimated from the urine samples, was the highest
for DEHP. Comparing medians, daily intakes for DnBP and DiBP
were around 70% of that for DEHP, while DEP and BBzP intakes
were considerably lower. The daily total intake from indoor
exposures (dust ingestion, inhalation and dermal absorption) was
the lowest for BBzP and the highest for DiBP. The largest intake
resulting from dust ingestion was that for DEHP, while the largest
by inhalation and dermal absorption was the intake of DiBP.
Statistically significant positive Spearman correlation coefficients
were obtained between the total daily intakes (DIurine) and the
corresponding day-specific daily intakes from the three pathways
(DIindoors) for DEP, DnBP, DiBP and BBzP (Table 4). Table 5
summarizes the descriptive statistics for the average daily intake as
estimated from a week-long exposure via each ‘‘indoor’’ pathway.
Although these intakes via all pathways, as well as the
corresponding total indoor intakes, were higher than their day-
specific counterparts, the trends described above are similar in
Tables 3 and 5.
The three indoor exposure pathways accounted for a meaningful
fraction of the total daily intakes (DIurine) of DEP, DnBP and DiBP
(Table 6). The entire DEP intake could be explained by exposures
in the indoor environment, while indoor exposures were re-
sponsible for ,50% and ,17% of the DiBP and DnBP intake,
respectively. For all three phthalates, dermal absorption was by far
the major route of intake indoors, while inhalation was roughly 1/
10th of the dermal pathway and dust ingestion an even smaller
percentage. For BBzP and DEHP, the indoor exposure pathways
made smaller contributions to the total intake than was the case for
DEP, DnBP and DiBP. For these higher molecular weight
phthalates, dust ingestion made the largest contribution of the
indoor pathways. Although not directly comparable, the total daily
indoor intakes estimated from a week-long exposure (WIindoors/7)
would explain 159% of DIurine for DEP, 28% for DnBP, 65% for
DiBP, 6% for BBzP and 19% for DEHP (data not shown),
compared to 102%, 17%, 50%, 3% and 8% explained by DIindoors,
respectively.
More than 80% of the weekly intake of DEP, DnBP and DiBP
from the indoor environment was attributable to dermal
absorption of these compounds from the air (Table 7). Another
,10% came from inhalation, while dust ingestion contributed
very little to the total intake. On the other hand, 75% and 95% of
the weekly indoor intake of BBzP and DEHP, respectively, entered
the body via dust ingestion. The exposure to gas-phase BBzP
through skin was responsible for,17% of the total intake from the
three pathways. For all phthalates, the intake through dermal
contact with adhered dust (WIdermal_dust) contributed negligibly to
the total intake (,1%).
More than 75% of WIindoors of DEP and DiBP came from
exposure in the home (Table S2) as opposed to exposures in the
daycare center. This is due to the relationship between the dust
mass fractions of these phthalates and the exposure time in the two
environments. For both phthalates, there was a large contribution
from dermal absorption, which during the course of a week
occurred for a longer time in the home. At the same time, the mass
fraction of DEP in the dust was nearly the same in the homes and
daycares (1.7 vs. 2.2 mg/g), while for DiBP the median mass
fraction was slightly higher in the homes than in daycares (27 vs.
23 mg/g; [79]). With 84% of the DnBP intake coming from
dermal exposure, a slightly higher fraction of the total DnBP
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intake originated in the home environment, even though the
median dust mass fraction of DnBP was ,2.5 times higher in the
daycare centers than in the homes. The higher-molecular-weight
phthalates mainly entered the body through dust ingestion, which,
during weekdays, occurred to a larger extent in the daycare
centers than in the homes (24 mg of ingested dust per day at
daycare vs. 20 mg at home). The mass fractions of BBzP and
DEHP in the dust were substantially higher in the daycares than in
the homes. Consequently, 67% of the BBzP intake from indoors
and 60% of the DEHP intake from indoors were attributable to
the daycare environment.
The daily phthalate intakes occasionally exceeded the tolerable
daily intake (TDI) established by the European Food Safety
Authority (Figure 2; Table 8). In 23 children (5.3%) the daily
intake of DiBP, determined from the urinary concentration of its
monoester metabolite, exceeded the limit value; in 22 children the
daily intake of DnBP exceeded its TDI; and in 3 children the daily
intake of DEHP exceeded its TDI. None of the children had
intakes that exceeded the TDI for DEP and BBzP. The median
fractions of TDI reached by the total intake of phthalates were
between 0.1% for DEP and BBzP and 33% for DnBP. Five
percent of children with the highest intake of DnBP and DiBP had
an intake above 100% and 102% of the TDI, respectively. The
average daily intakes based on a week-long exposure in the indoor
environment exceeded the TDI for fewer children. Interestingly,
14 children (3.2%) still exceeded the TDI for DiBP via the three
Figure 1. Cumulative frequency distributions for the estimated intakes of phthalates. Distributions are shown for the intakes on the day
before urine sampling by different indoor exposure pathways and the total intakes calculated from the metabolite concentrations measured in urine
(DIurine). A) DEP, B) DnBP, C) DiBP, D) BBzP and E) DEHP. The solid horizontal line indicates the TDI value. The TDI value for BBzP (500 mg/d/kg-bw) is
not indicated in the plot.
doi:10.1371/journal.pone.0062442.g001
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indoor exposure pathways. These children were not identical to
the ones that exceeded the TDI based on the urinary metabolite
levels. The total DEHP intake of 16 children (3.7%) exceeded the
RfD. The indoor environment contributed very little to the DEHP
intake (see Table 6), and the children’s intake from the three
indoor pathways did not exceed the RfD. None of the children
had an intake of BBzP that exceeded its RfD.
At the median level, the total intakes, as estimated from the
urine samples, were 9% of the TDI for DEHP, 33% for DnBP and
29% for DiBP. These three phthalates had a median summed
intake that was 79% of TDIcum. The 95
th percentile of the summed
intake was 223% of TDIcum. 131 out of 431 children (30%) had
a summed intake of these three phthalates that exceeded TDIcum,
indicating that nearly every third child’s cumulative daily
phthalate intake surpassed the tolerable levels (Figure 2; Table 8).
Table 3. Descriptive statistics regarding the intake of five phthalates (mg/d/kg-bw) calculated from urinary metabolite
concentrations and estimated from exposure via three pathways in the indoor environment on the day before urine sampling.
DEP DnBP DiBP BBzP DEHP
DIurine Mean (SD) 1.19 (2.33) 4.65 (9.07) 4.13 (8.19) 0.91 (1.63) 7.4 (26.2)
GM (GSD) 0.61 (3.2) 3.18 (2.2) 2.83 (2.2) 0.50 (2.9) 4.49 (2.3)
Min 0.017 0.25 0.26 0.023 0.38
Max 33.0 162.9 152.4 22.3 533.3
Median 0.62 3.26 2.93 0.49 4.42
95th %tile 3.89 10.03 10.02 2.79 16.9
DIingest_dust Mean (SD) 0.057 (0.32) 0.04 (0.04) 0.062 (0.16) 0.02 (0.03) 0.51 (0.65)
GM (GSD) 0.005 (7.3) 0.02 (3.9) 0.027 (4.4) 0.01 (3.4) 0.37 (2.1)
Min 0.0003 0.0002 0.0003 0.0006 0.04
Max 5.63 0.31 2.36 0.32 8.09
Median 0.003 0.03 0.035 0.009 0.35
95th %tile 0.20 0.10 0.16 0.075 1.53
DIinhalation Mean (SD) 1.56 (8.91) 0.081 (0.094) 0.26 (0.70) 0.002 (0.004) 0.04 (0.05)
GM (GSD) 0.13 (6.8) 0.043 (4.0) 0.1 (4.8) 0.001 (3.4) 0.028 (2.1)
Min 0.012 0.0004 0.001 0.000 0.003
Max 159.4 0.76 10.7 0.04 0.67
Median 0.071 0.058 0.14 0.001 0.026
95th %tile 5.76 0.24 0.66 0.009 0.11
DIdermal_gas
a Mean (SD) 10.9 (63.7) 0.73 (0.85) 2.44 (7.26) 0.006 (0.011) 0.007 (0.01)
GM (GSD) 0.89 (7.0) 0.39 (4.1) 0.95 (4.9) 0.003 (3.4) 0.005 (2.1)
Min 0.11 0.005 0.012 0.0003 0.0006
Max 1175.8 7.26 104.5 0.12 0.13
Median 0.45 0.51 1.33 0.003 0.005
95th %tile 41.1 2.13 6.15 0.024 0.02
DIindoors
b Mean (SD) 12.5 (72.9) 0.84 (0.98) 2.75 (8.11) 0.029 (0.047) 0.56 (0.71)
GM (GSD) 1.03 (6.9) 0.45 (4.0) 1.08 (4.9) 0.01 (3.4) 0.41 (2.1)
Min 0.12 0.005 0.013 0.001 0.04
Max 1340.8 8.34 117.5 0.47 8.88
Median 0.53 0.60 1.52 0.01 0.37
95th %tile 47.1 2.49 6.99 0.10 1.63
DIother
c Mean (SD) 211.3 (72.6) 3.81 (9.10) 1.38 (11.4) 0.88 (1.62) 6.84 (26.2)
GM (GSD) 0.40 (3.7)d 2.43 (2.9)d 1.81 (3.4)d 0.47 (3.1)d 3.80 (2.7)d
Min 21334.0 23.49 2113.0 20.06 23.94
Max 32.7 162.7 146.2 22.2 532.9
Median 20.022 2.59 1.24 0.46 3.94
95th %tile 1.81 9.56 8.09 2.74 16.6
SD-standard deviation, GM-geometric mean, GSD-geometric standard deviation.
aDue to negligible contribution, detailed data for DIdermal_dust are not presented. Its medians are: 0.00007 (DEP), 0.0005 (DnBP), 0.0006 (DiBP), 0.00007 (BBzP), 0.0004
(DEHP).
bSum of DIingest_dust, DIinhalation, DIdermal_gas on a child-by-child basis.
cDIother = DIurine – DIingest_dust – DIinhalation – DIdermal_gas.
dBased on positive values only: n = 214 (DEP), 403 (DnBP), 313 (DiBP), 429 (BBzP), 423 (DEHP).
doi:10.1371/journal.pone.0062442.t003
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Looking at the daily indoor intakes, based on one-week averages
(WIindoors/7), the children’s summed median intake was approxi-
mately a third of TDIcum. A meaningful fraction of the children (26
out of 431 or 6%) had summed intakes from the three indoor
pathways that exceeded TDIcum.
Discussion
Total Intake Based on Metabolites in Urine Samples
Although there are numerous studies of phthalate intakes for
adults (see summary in Wittassek et al. [68] and recent results in
Guo et al. [106], Ye et al. [107] and Chen et al. [108]), we will
compare our phthalate intake estimates with those of studies that
focused on children (Table 9). This approach is reasonable given
the physiological and potential toxicokinetic differences, age-
dependent metabolism and differences in exposure to phthalates
between adults and children [41],[109],[110],[111],[112], [113].
Table 9 is based on estimates derived from metabolite excretions
in urine, while Table S3 is based on estimates derived from
exposure to different media (food, air, water, soil, dust; see part A
of Discussion S1).
Children’s phthalate intakes, calculated from urinary phthalate
metabolite concentrations, are remarkably similar among the
studies listed in Table 9. These studies were made in several
countries and span the period from 2001 to 2010; the highest daily
intakes were found for DEHP, and the lowest for BBzP. Using the
volume-based method, slightly higher intakes of DnBP and DEHP
were reported for Asian countries, as well as in Germany about
a decade ago. The recent Danish study by Frederiksen et al. [113]
Table 4. Spearman correlation coefficients between
phthalate intakes calculated from urinary phthalate
metabolite concentrations (DIurine) and from the exposure to
phthalates via three pathways in the indoor environment on
the day before urine sampling (DIindoors).
DIurine
DEP DnBP DiBP BBzP DEHP
DIindoors DEP 0.30
a 0.073 0.047 0.021 0.041
DnBP 0.092 0.14b 0.007 0.076 0.113c
DiBP 0.103c 0.052 0.12c 0.02 0.009
BBzP 0.068 0.098c 0.011 0.21a 0.044
DEHP 0.02 0.055 20.071 0.068 0.026
ap,0.001,
bp,0.005,
cp,0.05.
doi:10.1371/journal.pone.0062442.t004
Table 5. Descriptive statistics of the average daily phthalate intake (mg/d/kg-bw) from a week-long exposure via three pathways in
the indoor environment.
DEP DnBP DiBP BBzP DEHP
WIingest_dust/7 Mean (SD) 0.074 (0.42) 0.076 (0.067) 0.092 (0.21) 0.041 (0.054) 1.04 (0.94)
GM (GSD) 0.009 (5.6) 0.056 (2.3) 0.055 (2.6) 0.024 (2.7) 0.83 (1.8)
Min 0.0006 0.0004 0.0005 0.001 0.15
Max 7.57 0.50 3.19 0.36 8.86
Median 0.005 0.055 0.057 0.022 0.78
95th %tile 0.27 0.22 0.21 0.12 2.85
WIinhalation/7 Mean (SD) 1.78 (10.2) 0.13 (0.12) 0.32 (0.80) 0.004 (0.005) 0.061 (0.063)
GM (GSD) 0.19 (5.7) 0.093 (2.4) 0.17 (3.0) 0.002 (2.7) 0.048 (1.9)
Min 0.019 0.0008 0.002 0.0001 0.009
Max 183.9 0.94 12.4 0.045 0.70
Median 0.11 0.094 0.19 0.002 0.043
95th %tile 6.66 0.35 0.80 0.012 0.17
WIdermal_gas/7 Mean (SD) 12.1 (71.2) 1.10 (1.04) 2.91 (8.13) 0.009 (0.013) 0.010 (0.011)
GM (GSD) 1.25 (5.9) 0.77 (2.4) 1.49 (3.1) 0.005 (2.8) 0.008 (1.9)
Min 0.15 0.007 0.016 0.0004 0.002
Max 1319.9 8.71 117.6 0.14 0.13
Median 0.69 0.81 1.69 0.005 0.007
95th %tile 46.2 3.04 7.09 0.034 0.029
WIindoors
/7 a Mean (SD) 13.9 (81.9) 1.30 (1.22) 3.32 (9.13) 0.054 (0.071) 1.11 (1.01)
GM (GSD) 1.45 (5.9) 0.92 (2.4) 1.72 (3.0) 0.032 (2.7) 0.89 (1.8)
Min 0.17 0.008 0.018 0.002 0.16
Max 1511.4 10.1 133.2 0.54 9.69
Median 0.80 0.97 1.95 0.030 0.83
95th %tile 53.1 3.50 7.97 0.16 3.07
SD-standard deviation, GM-geometric mean, GSD-geometric standard deviation.
aWIindoors is the sum of WIingest_dust, WIinhalation, WIdermal_gas on a child-by-child basis.
doi:10.1371/journal.pone.0062442.t005
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provides the most straightforward comparison with our results.
Although the children were somewhat older in the Frederiksen
study, very similar intake values were obtained for most phthalates.
The largest relative difference was for BBzP, where we observed
intakes about half of those reported by the mentioned study.
Currently we can only speculate about the reasons for this
difference. One plausible explanation could be smaller exposure to
BBzP due to differences in housing and lifestyle between residents
of Odense and Copenhagen, where Frederiksen et al. [113]
conducted their study. Dwellings in Copenhagen tend to be older.
Due to lower turnover of materials in the Copenhagen buildings,
they may contain more materials plasticized with BBzP. More-
over, while our study relied on first morning urine, the results in
the Copenhagen study are based on 24-hour urine samples. Our
results are also similar within a factor of two to those reported in
a recent German study by Koch et al. [26]. However, these results
were obtained with the creatinine-based method which can give
lower results than the volume-based method, as was observed in
an earlier German study [63],[65].
The median concentrations of the metabolites in the urine
samples tended to be slightly higher in girls than in boys, except for
the DEHP metabolites, which were slightly higher in boys. The
differences were not statistically significant [80]. The total
phthalate intakes (DIurine) had the same tendency (data not shown).
Again, the differences were not significant (Student’s two sample t-
test and Wilcoxon rank-sum test). These findings are in agreement
with the results of Koch et al. [26] and Frederiksen et al. [113].
Table 6. Contribution (%) of each exposure pathway on the day before urine sampling to the daily intake estimated from urinary
metabolite concentrations (DIurine).
DEP DnBP DiBP BBzP DEHP
DIingest_dust/DIurine6100 Mean (SD) 7.0 (26.1) 1.5 (2.7) 2.7 (7.2) 5.1 (9.8) 15.0 (21.3)
GM (GSD) 0.8 (7.5) 0.7 (4.6) 1.0 (5.1) 2.0 (4.2) 8.3 (3.0)
Min 0.004 0.002 0.002 0.02 0.06
Max 379 39.2 111 128 175
Median 0.50 0.8 1.2 2.0 7.6
95th %tile 29.3 5.0 8.8 19.1 52.3
DIinhalation/DIurine6100 Mean (SD) 189 (714) 3.2 (5.9) 11.0 (31.9) 0.6 (1.2) 1.1 (1.8)
GM (GSD) 21.5 (7.1) 1.4 (4.6) 3.6 (5.5) 0.2 (4.2) 0.6 (3.0)
Min 0.1 0.005 0.009 0.003 0.005
Max 10665 87.6 501 16.3 14.6
Median 12.8 1.6 4.6 0.2 0.6
95th %tile 830 11.4 37.2 2.3 3.9
DIdermal_gas/DIurine6100 Mean (SD) 1300 (4772) 28.9 (54.1) 105 (341) 1.5 (3.1) 0.2 (0.3)
GM (GSD) 147 (7.2) 12.1 (4.6) 33.5 (5.6) 0.6 (4.2) 0.1 (3.0)
Min 0.80 0.06 0.1 0.01 0.001
Max 69469 806 6036 40.8 3.0
Median 89.2 14.2 44.0 0.6 0.1
95th %tile 5279 108 338 6.5 0.7
DIindoors
a/DIurine6100 Mean (SD) 1497 (5510) 33.6 (62.5) 118 (379) 7.2 (14.0) 16.3 (23.4)
GM (GSD) 169 (7.1) 14.2 (4.6) 38.1 (5.5) 2.8 (4.2) 9.0 (3.0)
Min 0.9 0.07 0.1 0.03 0.07
Max 80513 933 6648 185 192
Median 102 16.5 49.9 2.9 8.2
95th %tile 6021 122 382 27.6 57.0
SD-standard deviation, GM-geometric mean, GSD-geometric standard deviation.
aSum of DIingest_dust, DIinhalation, DIdermal_gas on a child-by-child basis.
doi:10.1371/journal.pone.0062442.t006
Table 7. Contribution (%) of each exposure pathway to the
weekly intake from indoors (WIindoors).
DEP DnBP DiBP BBzP DEHP
WIingest_dust/
WIindoors
a6100
GM 0.6 6.0 3.2 75.6 93.5
Median 0.6 6.0 3.0 76.8 93.6
WIinhalation/
WIindoors
a6100
GM 13.2 10.0 9.8 6.5 5.4
Median 13.2 10.0 9.7 6.4 5.4
WIdermal_gas/
WIindoors
a6100
GM 86.0 83.6 86.8 16.7 0.9
Median 86.1 83.9 87.1 16.5 0.9
WIdermal_dust/
WIindoors
a6100
GM 0.01 0.08 0.04 0.5 0.09
Median 0.01 0.08 0.04 0.4 0.09
GM-geometric mean.
aTo indicate the negligible contribution of WIdermal_dust, WIindoors here is the sum
of WIingest_dust, WIinhalation, WIdermal_gas and WIdermal_dust.
doi:10.1371/journal.pone.0062442.t007
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Koch et al. [63] and Wittassek et al. [65] found higher intake of
DEHP and BBzP but not of DnBP for boys. We found no
significant differences between boys and girls when comparing the
daily intakes estimated from the phthalate mass fractions in the
dust. Furthermore, we found only slight (and not statistically
significant) differences between cases and bases when comparing
daily intakes. Additional discussion regarding differences in daily
intakes between cases and bases can be found in part B of
Discussion S1.
Our intakes of DEP were lower while intakes of DEHP were
somewhat higher than those estimated by Calafat and McKee
[115] from urinary levels reported in other studies. The estimates
of exposures to these phthalates by Calafat and Mckee [115] were
made using geometric mean urinary phthalate metabolite con-
centrations and not on a child-by-child basis. The higher intakes of
DEP in the US studies may reflect a different pattern of use for
personal care products in the US compared to Denmark.
A reasonably good agreement was found between the fairly
complete scenario-based exposure assessment by Wormuth et al.
[41] and our total daily intakes with the largest difference obtained
for DiBP (see Table S3). It is important to note, that according to
CDC’s NHANES data, only the levels of MiBP in children’s urine
have increased during the last decade, while metabolite concen-
trations of other phthalates have decreased during this time [109].
Similar trends have been reported by Wittassek et al. [66] and
Go¨en et al. [118] based on data collected from university students
Figure 2. Cumulative frequency distribution of the ratio of the daily intake to the TDI for each of the five phthalates. The solid
diamonds depict the relative cumulative tolerable daily intake (TDIcum) for DnBP, DiBP and DEHP; A) daily intakes calculated from the excreted
amount of phthalates in the urine (DIurine), B) average daily intakes from a week-long exposure in the indoor environment through dust ingestion,
inhalation and dermal absorption. Values above the solid horizontal line (100%) exceed the TDI of the given phthalate or the TDIcum for the three
phthalates.
doi:10.1371/journal.pone.0062442.g002
Table 8. Portions (%) of the tolerable daily intakes (TDI), cumulative tolerable daily intake (TDIcum) and reference dose (RfD for
DEHP) reached by the daily phthalate intake calculated from urinary concentrations (DIurine) and from a week-long exposure via
three pathways in the indoor environment (WIindoors/7).
DEP DnBP DiBP BBzP DEHP TDIcum
a DEHP (RfD)
DIurine/TDI6 100 #(%) above 100%
b 0(0) 22(5) 23(5) 0(0) 3(0.7) 131(30) 16(4)
Mean 0.2 47 41 0.2 15 103 37
GM 0.1 32 28 0.1 9.0 75 22
Min 0.003 2.5 2.6 0.005 0.8 7.3 1.9
Max 6.6 1629 1524 4.5 1067 1773 2667
Median 0.1 33 29 0.1 8.8 79 22
95th %tile 0.8 100 102 0.6 33 223 84
(WIindoors/7)/TDI6 100 #(%) above 100%
b 2(0.5) 1(0.2) 14(3) 0(0) 0(0) 26(6) 0(0)
Mean 2.7 13 33 0.01 2.2 48 5.6
GM 0.3 9.2 17 0.006 1.8 33 4.4
Min 0.03 0.08 0.2 0.0004 0.3 2.3 0.8
Max 302 101 1330 0.1 19 1340 48
Median 0.2 9.7 20 0.006 1.7 33 4.2
95th %tile 11 35 80 0.03 6.1 109 15
GM-geometric mean.
aBased on (DnBP+DiBP+DEHP).
bNumber (percentage) of children whose values exceed the TDI, TDIcum or RfD.
doi:10.1371/journal.pone.0062442.t008
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in Germany over a period of 20 years. Koch et al. [26] argue that
the decrease in the daily intake of DnBP by a factor of 2 between
two studies performed in 2001/2 and 2007 might be explained by
the substitution of DnBP with DiBP that took place in the years
between the two studies. This was supported by the authors’
observation that DiBP intake roughly matched the drop in DnBP
intake.
Intake from Exposures in the Indoor Environment
In Langer et al. [80] we presented Spearman correlation
coefficients for the various pairings of phthalate diesters in settled
dust and metabolite levels measured in the children’s urine.
Statistically significant positive correlations were observed between
DEP and MEP, DnBP and MnBP, DiBP and MiBP, and BBzP
and MBzP. No significant correlation was observed between
DEHP in dust from the bedrooms/daycare centers and any of its
metabolites in the children’s urine. It is noteworthy that in the
current work we found nearly identical correlation coefficients
with the same statistical significance between the daily intakes
calculated from the urinary metabolite concentrations (DIurine) and
the corresponding day-specific daily intakes estimated from the
levels of phthalates in the dust (DIindoors) (Table 4).
Estimated intakes from exposures in the indoor environment
were responsible for a large fraction of the total intakes of DEP
and DiBP and contributed meaningfully to the total intake of
DnBP. Most of the intake from indoors occurred via dermal
absorption. In the case of DEP, estimated intakes from dermal
absorption often exceeded total intakes estimated from urine
samples. A similar pattern was seen by Guo and Kannan [43]. In
their case they suggested that intakes estimated from urinary
metabolites may underestimate actual total DEP intakes, or that
the dermal absorption coefficient they used to estimate intakes
from personal care products may have been too large. In our case,
it may also reflect an imperfect estimate of gas-phase concentra-
tions or an overestimated dermal permeability coefficient. Dust
ingestion contributed ,1% or less to the total intake (DIurine) of
these phthalates. This is comparable to the findings of Guo and
Kannan [43] and Wormuth et al. [41] for children of 4–10 years,
while the latter found a larger DiBP intake from dust ingestion for
children below 4 years. Of the total intake, inhalation contributed
between 1.6% for DnBP to 12.8% for DEP, which is slightly lower
than in Wormuth et al. [41]. However, except for DiBP, these
results are consistent with those of Guo and Kannan [43] for
children and those of Itoh et al. [42] for adults. A relatively small
contribution from inhalation was also reported by Chan and Meek
[72], Fromme et al. [75] and Little et al. [54].
The intake fraction that our estimates do not account for (DIother)
includes intakes that occur in other environments than the home
or daycare and other routes of exposure, such as diet, mouthing of
objects, dermal absorption by contact with dust or personal care
Table 9. Daily phthalate intakes (mg/d/kg-bw) of children calculated from urinary phthalate metabolite concentrations.
Reference/gender/age
Survey
years Country n DEP DnBP DiBP BBzP DEHP
Koch et al. and Wittassek et al. [63,65],
boys (2–14 yrs)
01–02 Germany 106 – 4.46b(7.04) – 0.48b(0.91) 4.9b(8.4)
Koch et al. and Wittassek et al. [63,65],
girls (2–14 yrs)
01–02 Germany 133 – 4.74b(7.76) – 0.31b(0.72) 3.9b(7.4)
Koch et al. [26], (5–6 yrs) 07 Germany 108 – 1.9b 2.1b 0.3b 4.5b
Lin et al. [114], (2–3 yrs) 03–04 Taiwan 30 – 3.81a 1.28a 0.17a 8.1a
Lin et al. [114], (5–6 yrs) 06–07 Taiwan 59 – 5.29a 0.91a 0.17a 10.9a
Guo et al. [106], boys (,10 yrs) 10 China 7 0.8 6.1 – – 3.4
Guo et al. [106], girls (,10 yrs) 10 China 3 0.1 0.6 – – 14.6
Frederiksen et al. [113], boys (6–10 yrs) 07 Denmark 25 0.92 5.27j 0.96 5.67
Frederiksen et al. [113], girls (6–10 yrs) 07 Denmark 24 1.13 5.28j 0.97 5.37
Frederiksen et al. [113] (6–21 yrs) 07 Denmark 129 1.09 4.29j 0.62 4.04
This study, (3–6 yrs) 08–09 Denmark 431 0.62 3.26 2.93 0.49 4.42
Estimated daily phthalate intakes reported in Calafat and McKeeb [115]
6–11 yrsc 99-00 USA 328 1.7a – – – 0.6a
6–11 yrsd 99-02 USA 392 1.8a – – – 0.6(2.4;2.6)h,a
3–14 yrse 01-02 Germany 254 – – – – 0.7(2.6;3.1)h,a
,7 yrsf 03 Germany 36 – – – – 1.0(3.5;3.8)h
12–18mthsg 00 USA 19 6.3i – – – 2.8i
All values are medians except when indicated otherwise.
aGeometric Mean.
bDaily intakes from creatinine-based model, (from volume-based model in parentheses, when present).
cEstimated using urinary concentrations from Silva et al. [111].
dEstimated using urinary concentrations from CDC [116].
eEstimated using urinary concentrations from Becker et al. [112].
fEstimated using urinary concentrations from Koch et al. [110].
gEstimated using urinary concentrations from Brock et al. [117].
hfrom MEHP (MEHHP; MEOHP).
iMean value.
jMnBP+MiBP.
doi:10.1371/journal.pone.0062442.t009
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products or ingestion of soil and personal care products. This
contribution from other environments and pathways was re-
sponsible for about 85% of the total intake of DnBP and 50% of
the total intake of DiBP. Presumably, a substantial fraction of this
is due to diet, mouthing of toys and exposure to personal care
products [41],[43],[74],[119],[46],[120], [45],[121]. However,
Guo et al. [122] compared daily intakes of phthalates estimated
from phthalate levels measured in foodstuffs in China with total
intakes estimated from earlier published biomonitoring data. The
authors concluded that diet may contribute less than 10% to the
total intake of low-molecular-weight phthalates. In a 48 hour
fasting study, Koch et al. [64] observed that non-dietary pathways
are primarily responsible for exposure to low-molecular-weight
phthalates. Some of the other sources of exposure, especially
personal care products, also contribute to the total intake of DEP
[64]. We suspect that our calculated values for DEP intake from
dust ingestion, inhalation and dermal absorption are over-
estimated. Reasons for this are discussed in the previous paragraph
(dermal pathway) and in the subsection ‘‘Limitations of the study’’.
Indoor environmental exposures contributed very little to the
total intake of the high-molecular-weight phthalates. This is of no
surprise for DEHP, given the large number of studies indicating
that diet is the major route of exposure for this compound
[41],[75],[69],[42],[43],[123],[122],[64],[76],[108],[70], [124].
Given DEHP’s relatively high mass fraction in dust [79] and low
inferred airborne concentration, it is reasonable that dust ingestion
was the strongest contributor (.90%) to the total intake from the
three non-diet pathways assessed in this study. An identical result
was reported by Little et al. [54]. For the younger children in our
study, mouthing of objects may also have contributed to the total
intake. Given the comparable properties and similar uses of other
high-molecular-weight phthalates such as di(isononyl) phthalate
(DiNP), di(isodecyl) phthalate (DiDP) and di(propylheptyl) phtha-
late (DPHP), similar contributions from the three pathways in the
indoor environment to the total intake may be expected for these
phthalates. The significant correlation between BBzP in dust and
MBzP in urine [80] would suggest that indoor environmental
exposures play a meaningful role in BBzP’s total intake. This is
somewhat at odds with our current results. However, our results
are in line with those of of Wormuth et al. [41], Itoh et al. [42]
and Guo and Kannan [43], which found significant BBzP intake
from diet, personal care products and sprays.
Most studies estimating dermal exposure to phthalates assume
that absorption takes place following topical application of
personal care products [125],[7],[45] or direct contact with
phthalate containing surfaces [126]. To our knowledge, only
a few papers have considered dermal absorption of gas-phase
phthalates as a possible source of exposure. Xu et al. [52],[53]
estimated the exposure to DEHP from vinyl flooring via inhalation
of vapor, inhalation of particles, dermal absorption of DEHP
transported to the skin from the gas-phase, and oral ingestion of
household dust. Although the primary route of exposure was dust
ingestion, the authors concluded that dermal absorption of DEHP
deposited on skin can be greater than that taken up through
inhalation. Carlstedt et al. [127] found significantly higher urinary
levels of MBzP among infants with larger body area and PVC
flooring in their bedrooms. Transdermal uptake from air is
anticipated to be even more pronounced for low-molecular-weight
phthalates, which have a large fraction of their total airborne
concentration in the gas phase [51]. Little et al. [54] estimated that
almost 60% of a child’s indoor exposure to DnBP (emitted from
a single product) occurs via dermal absorption from the gas phase.
For all three low-molecular-weight phthalates in our study, by far
the largest fraction (.80%) of the total indoor intake was
a consequence of dermal absorption from the gas-phase (Table 7).
The permeability coefficients that are used to estimate dermal
absorption of these phthalates from the gas phase are based on
physical-chemical considerations rather than actual measure-
ments. We anticipate that in the future measurements will be
conducted that confirm these calculated permeability coefficients.
In the meantime, experimental reassurance regarding the reason-
ableness of these calculations is provided by studies that have
measured the transdermal permeation of DEP and DnBP when
present in solutions or creams applied to the surface of human
skin. In a 1995 study Hagedorn-Leweke et al. [128] measured
a dermal flux of , 105 mg/m2/h for DnBP from a propylene
glycol/water solution saturated with DnBP. More recently,
metabolites of DEP and DnBP have been measured in serum
[48] and urine [49] following topical application of a cream
containing 2% DEP and 2% DnBP. A flux of 830 mg/m2/h was
measured for DEP, while a flux of 250 mg/m2/h was measured for
DnBP. These studies demonstrate that both DEP and DnBP
rapidly penetrate the skin. Diffusive transport from the gas phase
to skin surface lipids initiates the contact with the skin. Indeed, the
transport of DnBP from the gas phase to the skin and subsequent
partitioning into skin surface lipids has been inferred from
simultaneous measurements of air and handwipe levels of DnBP
[51]. In brief, we feel that the available evidence supports the
approach that we have used to estimate dermal intakes of gaseous
phthalate esters.
As expected, dermal absorption from dust adhered to skin had
a negligible effect on the total phthalate intake. The median intake
on the day before urine sampling (DIdermal_dust) was one to three
orders of magnitude lower than the intakes by the other three
exposure routes. There are however several sources of uncertainty
in these estimates. There is limited data in the literature on the
amount of dust adhered to skin. Additionally, the dermal uptake
rates for dust, adapted from Wormuth et al. [41], were based on
the uptake rates for cosmetics directly applied onto skin, corrected
with a factor of 0.15 to account for the matrix effect. We were
unable to find specific data for each phthalate and the same matrix
value was applied for all target phthalates. Further discussion of
the contribution to the total phthalate intake of dust adhered to
skin is presented in part C of Discussion S1.
Comparison with Tolerable Daily Intake (TDI) Values
Assuming that DiBP and DnBP have similar TDIs, the total
DiBP intake of 23 children exceeded the putative TDI. This was
the highest number of exceedences among the five phthalates,
followed by 22 children, whose total DnBP intake exceeded its
respective TDI. The median intakes of DnBP, DiBP and DEHP
corresponded to 33, 29 and 9% of their respective TDIs,
comparable to the values of 19%, 21% and 8.9% reported by
Koch et al. [26] and 53% for the sum of DnBP and DiBP, and
11% for DEHP calculated from median intake values for children
of age 6–10 years, reported by Frederiksen et al. [113]. Although
the daily intake of DEHP calculated from the urinary concentra-
tions was the highest among the five phthalates, only 3 total intake
values exceeded the TDI for DEHP. The US EPA’s Reference
Dose for DEHP is based on increased relative liver weight instead
of reproductive and developmental effects [98], and its value was
exceeded by 16 children.
Somewhat surprisingly, 14 children exceeded the TDI of DiBP,
based only on exposures that occurred in indoor environments.
These children were not necessarily the same children whose total
intake calculated from their urinary levels exceeded the TDI. 11
out of the 14 children had an intake via dermal absorption alone
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(WIdermal_gas/7) exceeding the TDI. It is important to note, that the
current TDI values are based on dietary or total intake of
phthalates and are most appropriate for dietary exposure. There
are no limit values for phthalate intake via other pathways.
However, the nature of the exposure pathway may have an impact
on the health effect of a contaminant. While ingested compounds
pass through the intestines and liver before entering the blood
stream, exposure via inhalation may impact the respiratory system
first. Transdermal exposure may impact the skin and can lead to
systemic effects by direct delivery of the contaminant to organs via
blood. Taken together, our intake estimates indicating that
transdermal exposure to DiBP may exceed tolerable daily intake
levels further support the potential significance of exposure to
phthalates in the indoor environment. These findings should be
confirmed and differences in health effects resulting from intakes
via different exposure pathways should be further investigated.
Applying the approach of a cumulative tolerable daily intake, as
recently introduced by Koch et al. [26], to the three phthalates for
which TDI values are available based on the same health endpoint
(effects on reproduction and development), we found that 30% of
children exceeded the TDIcum. This agrees with the results of Koch
et al. [26], who found exceedences of TDIcum in 25% of their study
population. Søeborg et al. [40] found 19 out of 129 (15%) Danish
children and adolescents between 6 and 21 years of age exceeding
the cumulative tolerable daily intake for these three phthalates. In
our study the cumulative intake of the three phthalates reached
,80% of TDIcum at the median level and ,220% at the 95th
percentile level, compared to 56% and 183%, respectively,
reported by Koch et al. [26] and 51% and 129%, respectively,
reported by Søeborg et al. [40] for older children and adolescents.
Calculating and summing the individual portions of TDI reached
by the median and 95th percentile intakes of DnBP+DiBP and
DEHP as reported in Frederiksen et al. [113] for children aged 6–
10 years, 64% and 235% of TDIcum would be reached,
respectively. Although this latter approach is imperfect, these
results reflect somewhat similar exposures of German and Danish
children to phthalates. The relatively high fraction of children
exceeding the TDIcum is noteworthy. The fact that 26 children (6%)
exceeded the TDIcum simply due to dust ingestion, inhalation and
dermal absorption of gas-phase phthalates, supports the hypothesis
that exposure to phthalates in the indoor environment can
substantially contribute to the total phthalate exposure.
Other common indoor pollutants are suspected endocrine
disruptors with anti-androgenic effects similar to those attributed
to DnBP, DiBP and DEHP. These include BBzP, diisononyl
phthalate (DINP), bisphenol A, selected polychlorinated biphenyls
(PCBs), selected polybrominated diphenyl ethers (PBDEs) and
pesticides such as vinclozolin, procymidone
[129],[36],[30],[33],[34],[130],[131]. As their anti-androgenic
properties are confirmed and reliable TDI values become
established, intakes of these compounds should be included when
calculating a summed intake to be compared to TDIcum. The
inclusion of additional indoor pollutants in such an assessment is
expected to increase the fraction of children whose net daily intake
of endocrine disrupting chemicals exceeds an established cumu-
lative TDI.
Limitations of the Study
To our knowledge, this is the largest study that compares
children’s phthalate intakes estimated from urinary phthalate
metabolite concentrations with intakes estimated from dust
ingestion, inhalation and dermal absorption. Moreover, this may
be the first study that performs these calculations on a child-by-
child basis while taking into account the children’s exposures in
both their home and daycare environments. Nevertheless, it is
important to recognize that our estimates of daily phthalate intakes
from the indoor environment required numerous assumptions and
approximations.
In the case of DnBP, DiBP, BBzP and DEHP, the ratio (Cdust/
Cg) was calculated using equation (8) and the appropriate Koa for
the phthalate in question. Koa was also used to calculate each
phthalate’s partitioning between the gas-phase and airborne
particles (equation (10)). Equation (8) is based on a limited number
of studies [56]. Additionally, values of Koa have not been
measured for these phthalates and have instead been estimated
using a structure-activity relationship (SPARC v4.6). These Koa
values could be off by an order of magnitude or more [132].
Moreover, to estimate the total airborne phthalate concentrations
(Cg+Cp), we assumed that all homes and daycare centers had the
same average indoor concentration of airborne particles (20 mg/
m3), and that these airborne particles had the same density and
volume fraction of organic matter. In actuality, each of these
parameters likely varied among the different indoor environments.
Of the phthalates targeted in this study, BBzP is the most sensitive
to errors in Koa and, to a lesser extent, in assumptions regarding
airborne particles. It is also the targeted phthalate for which there
appears to be no single dominant indoor pathway. An inaccurate
estimate of Koa for BBzP may be partially responsible for what
appear to be underestimated contributions from its indoor
pathways.
An additional error may stem from the limited accuracy of
phthalate metabolite concentrations in urine. We compared
metabolite concentrations determined by two different analytical
procedures for a subset of our urine samples [80]. The average
difference between the two methods was 30% for the geometric
mean concentrations of eight metabolites. In contrast, we judge
the analytical errors in the phthalate mass fractions in the dust to
be below 10%.
Several of the exposure input parameters are poorly character-
ized and some (e.g., inhalation rate, dust ingestion rate, fraction of
time spent in different environments) are anticipated to vary
among the children and over time. The dermal permeability
coefficients are based on the best available, but often limited,
knowledge [51]. Additionally, these coefficients do not account for
the fact that the skin of children may be more permeable than the
skin of adults [96].
The number of controlled studies on the metabolism of
phthalates in humans is small [87], and different urinary excretion
factors (Fue) are reported in the literature. For some of the
phthalates, Fue’s have been obtained from studies with only a few
adult volunteers [89],[133]. Furthermore, several papers suggest
that metabolism in children differs from that in adults
[112],[85],[110]. In the present study, we have used a urinary
excretion factor of 0.69 for DEP, DnBP and DiBP. A urinary
excretion factor has yet to be measured for DEP/MEP. After we
had completed our analysis, Koch et al. [101] reported a measured
urinary excretion factor of 0.71 for DiBP/MiBP – close to the
value that we used.
Comparisons of total intakes calculated from urinary metabolite
levels with intakes estimated from various exposure pathways,
including the calculation of DIother from equation (6), assume that
the fraction of a given phthalate excreted in urine is identical for
all exposure pathways. However, the urinary excretion factors
have been determined from excretion over a short time period
after controlled oral administration. Whether the fraction excreted
after inhalation or dermal absorption is the same as that following
ingestion is currently not known.
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Both DnBP and BBzP metabolize to form MnBP. In our
calculations we assumed that all MnBP was derived from DnBP.
However, we do not anticipate this fact to be a source of significant
error. According to Anderson et al. [133], less than 10% of BBzP
metabolizes to MnBP in humans.
The association between intakes estimated from the urinary
metabolite concentrations and intakes from dust mass fractions
may be influenced by the relatively long time (up to a year) that
elapsed between dust collection in the homes and daycare facilities
and urine sample collection. Moreover, the mass fractions of
phthalates in dust correspond to exposures over an extended
period of time, while levels of phthalate metabolites in urine
correspond to exposures that occurred over the previous 24 to 36
hours. Certain short-term conditions that we could not account for
(e.g. intake of phthalate-containing drugs [134],[135], foods or
beverages), may have influenced our intake estimates derived from
urine measurements. In spite of potentially large within-person
daily variability of urinary phthalate metabolites, some authors
have suggested that a single sample may reasonably predict
average metabolite concentrations over a period of several months
[136],[137],[138],[5].
Frederiksen et al. [113] observed substantially higher metabolite
levels in first morning urine samples compared to corresponding
24-hour urine samples. On the other hand, temporal variations in
metabolite concentrations in the urine during the course of a day
may differ between various monoesters, possibly reflecting
different exposures at different times of the day [111],[139],[123].
When estimating the contribution of inhalation to the total
intake, we assumed 100% retention and 100% absorption. This
may overestimate phthalate intake via the inhalation pathway.
Hawley et al. [96] assumed that 75% of inhaled particulate matter
is retained and 100% of the contaminant in inhaled dust is
absorbed. Wormuth et al. [41] assumed an overall uptake rate for
inhalation of 75% for adults and 100% for children. Jakubowski
and Czerczak [140] summarized experimental studies that de-
termined the rates at which various volatile organic compounds
(VOCs) present in inhaled air are retained in the lung. The lung
retention rates of the studied VOCs varied between 20–90%, and,
for certain compounds, changed with the duration of exposure.
Similarly, the arterial blood concentration resulting from the
inhalation of a phthalate is expected to depend on its gaseous
concentration, the duration of exposure, and its physicochemical
properties [141].
Regardless of these limitations, we believe that the present study
provides valuable insights regarding the relative contribution of
the indoor environment to the total phthalate exposure of Danish
children. Analyses of the relationship between daily phthalate
intakes in the present study and the children’s health status are
ongoing.
Conclusions
Total phthalate intakes calculated from metabolite levels in the
urine were comparable to those reported in recent studies
conducted in Denmark and Germany. Children’s exposure to
phthalates occurring indoors via dust ingestion, inhalation and
dermal absorption can meaningfully contribute to the total intake
of the low-molecular-weight phthalates such as DEP, DnBP and
DiBP. Dermal absorption and inhalation appear to be the most
important routes of environmental exposure for these chemicals.
Exposures occurring in indoor environments contributed only
a small fraction of the total intake for DEHP. Most of its exposure
attributable to the indoor environment occurred through dust
ingestion. However, less than 10% of its total daily intake came via
this pathway.
For 22 children, the total intake of DnBP from all sources and
exposure pathways exceeded its TDI. In the case of DiBP, the total
intake of 23 children exceeded its putative TDI (assumed to be the
same as that of DnBP). Even when only exposures that occurred in
the home and daycare environments were considered, a number
of children had DiBP intakes that exceeded the TDI. This may
reflect an increased substitution of DiBP for other phthalates found
in indoor environments [63],[26],[109],[118], [67],[66]. Nearly
every third child had a summed intake of DnBP, DiBP and DEHP
that exceeded the cumulative TDI of 100% for these compounds.
Considering exclusively exposures that occurred in the indoor
environment (daily indoor intakes based on one-week averages
(WIindoors/7)), 6% of the children had summed intakes of DnBP,
DiBP and DEHP that exceeded the cumulative TDI for these
three phthalates. Assuming that the metabolite levels in 24-hour
urine samples could be lower than in our first morning urines
[113], our current daily intakes estimated from the environmental
exposure in the home and daycare would constitute an even larger
fraction of the total intake. Taken together, the indoor environ-
ment appears to be an important source of phthalate exposure.
To better characterize exposure, further research is needed
regarding the absorption, distribution and elimination of phtha-
lates via different pathways, as well as the role of the exposure
pathway in determining various adverse health effects. Addition-
ally, future research should address the health effects of
simultaneous human exposure to multiple phthalates and other
potential endocrine disruptors.
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